Latest: BASF India Ltd Q1 FY27 results →All Q4 FY26 results →
B

BASF India Ltd

Q4 FY26Chemicals & Petrochemicals

BASF India Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management said on revenue, margins and capex.

Price₹3,903
Market cap₹17.5K Cr
P/E28.2
Updated23 Aug 2026
Read3 min read

What the Q4 FY26 call signalled

1 of 3 strong

RevenueSlow growth
MarginMargins steady
CapexCapex planned

The short version

India’s chemical market is expected to grow gradually, supported by a young demographic and low per capita chemical consumption relative to global averages (Page 9). BASF India's EBITDA has remained in a similar range over six years (Rs.

From BASF India Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

Slow growth
  • India’s chemical market is expected to grow gradually, supported by a young demographic and low per capita chemical consumption relative to global averages (Page 9).
  • BASF aims to expand its share across diverse industries including fast-moving consumer goods, construction chemicals, automotive, furniture, appliances, footwear, packaging (Page 12).
  • Agricultural solutions volume growth was negative in FY26 due to challenging market conditions, but BASF maintained market share (~7%) and expanded in fruits and vegetables segments (Page 11).
  • The company launched 12 new agro products in the last four years, contributing ~25% of ag division sales, signaling portfolio freshness and potential growth (Page 11).
  • Capital expenditure (~Rs. 200+ crore in FY27) on expansions like Celesto and dispersion line capacity increases indicates growth investment (Page 10).

2 more points from BASF India Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what BASF India Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • FY26 Capex was around Rs. 200 crore, including Rs. 150 crore spent on Celesto expansion (ongoing).
  • Celesto expansion is halfway complete; another Rs. 150-170 crore pending to bring it to production by end of FY27.
  • Dispersion line 3 in Mangalore is a significant Capex project, targeted for commissioning by end of FY28, adding ~15% capacity.
  • Maintenance Capex averages Rs. 82-100 crore annually, varies year to year.
  • No large new Capex similar to the 2014 multi-OD site Dahej investment is currently planned.
  • The focus is on maximizing utilization of existing assets and incremental capacity growth rather than large-scale investments due to global industry challenges (energy costs, overcapacity, geopolitical risks).

2 more points from BASF India Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

BASF India Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹3.5K Cr, net profit ₹64 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Indian Phosphate Ltd (Q4 FY26)

    H2 FY26 Revenue (Consolidated):** ₹580.25 Cr, up from ₹451.59 Cr in H2 FY25 — a year-on-year increase of ₹128.66 Cr. Key investor presentation takeaways from In

  • Vishnu Chemicals Ltd (Q4 FY26)

    Q4 FY26 Operating Revenues: ₹450.3 crore, up 14.7% YoY from ₹392.6 crore in Q4 FY25 (Page 5). Key investor presentation takeaways from Vishnu Chemicals Ltd's Q4

  • Rajputana Biodiesel Ltd (Q4 FY26)

    Revenue from Operations: ₹6,267.05 lakhs vs. Key investor presentation takeaways from Rajputana Bio.'s Q4 FY26 investor presentation — and how it ranks against

  • Neochem Bio Solutions Ltd (Q4 FY26)

    Capacity utilization improved from ~35% in FY24 to 53% in FY26, with significant headroom (47%) for growth without major capex. Key concall takeaways from…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

BASF India Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were BASF India Ltd Q4 FY26 results?

India’s chemical market is expected to grow gradually, supported by a young demographic and low per capita chemical consumption relative to global averages (Page 9). BASF India's EBITDA has remained in a similar range over six years (Rs.

What is BASF India Ltd share price analysis?

BASF India Ltd currently shows a neutral. The stock trades at a P/E of 28.2 with a market cap of ₹17,473 Cr. Investors should review the full earnings analysis for detailed insights.

Is BASF India Ltd planning capital expenditure?

FY26 Capex was around Rs.

Keep BASF India Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.